72.51
price down icon0.33%   -0.24
pre-market  プレマーケット:  73.44   0.93   +1.28%
loading
前日終値:
$72.75
開ける:
$73.5
24時間の取引高:
1.66M
Relative Volume:
1.05
時価総額:
$12.97B
収益:
$342.96M
当期純損益:
$-864.29M
株価収益率:
-13.06
EPS:
-5.55
ネットキャッシュフロー:
$-636.03M
1週間 パフォーマンス:
+11.13%
1か月 パフォーマンス:
-1.81%
6か月 パフォーマンス:
-4.01%
1年 パフォーマンス:
+151.68%
1日の値動き範囲:
Value
$71.50
$73.62
1週間の範囲:
Value
$63.73
$73.62
52週間の値動き範囲:
Value
$21.92
$80.53

Insmed Inc Stock (INSM) Company Profile

Name
名前
Insmed Inc
Name
セクター
Healthcare (1172)
Name
電話
908-977-9900
Name
住所
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
職員
912
Name
Twitter
@insmed
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
INSM's Discussions on Twitter

INSM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
INSM
Insmed Inc
72.51 12.97B 342.96M -864.29M -636.03M -5.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.00 108.68B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
681.58 74.90B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
640.52 38.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
246.27 31.76B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
111.93 26.83B 3.30B -501.07M 1.03B -2.1146

Insmed Inc Stock (INSM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-04-23 開始されました Truist Buy
2024-02-15 開始されました Wolfe Research Outperform
2023-12-08 開始されました Wells Fargo Overweight
2023-11-20 再開されました JP Morgan Overweight
2023-07-26 開始されました Guggenheim Buy
2022-12-09 開始されました Mizuho Buy
2022-12-07 開始されました Barclays Overweight
2022-11-18 開始されました BofA Securities Buy
2022-04-27 開始されました Goldman Buy
2021-12-06 開始されました JP Morgan Overweight
2021-10-19 再開されました Monness Crespi & Hardt Buy
2021-10-19 再開されました Morgan Stanley Overweight
2021-10-08 開始されました Cantor Fitzgerald Overweight
2021-04-26 再開されました Credit Suisse Outperform
2020-12-17 開始されました Berenberg Buy
2020-10-12 再開されました Stifel Buy
2019-09-03 開始されました Goldman Buy
2019-04-09 繰り返されました H.C. Wainwright Buy
2019-02-15 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2019-01-17 アップグレード Goldman Neutral → Buy
2019-01-02 開始されました Canaccord Genuity Buy
2018-08-06 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2018-07-23 開始されました Goldman Neutral
2018-04-23 アップグレード Credit Suisse Neutral → Outperform
2018-03-21 開始されました Morgan Stanley Overweight
2018-01-18 開始されました Credit Suisse Neutral
2017-09-05 繰り返されました Evercore ISI Outperform
2017-08-17 開始されました Evercore ISI Outperform
2017-07-11 開始されました Robert W. Baird Outperform
2016-03-15 開始されました Stifel Buy
2015-11-09 ダウングレード UBS Buy → Neutral
2015-10-06 繰り返されました H.C. Wainwright Buy
2015-06-09 開始されました Citigroup Neutral
2014-03-26 繰り返されました HC Wainwright Buy
すべてを表示

Insmed Inc (INSM) 最新ニュース

pulisher
06:36 AM

The five-year returns have been solid for Insmed (NASDAQ:INSM) shareholders despite underlying losses increasing - Yahoo Finance UK

06:36 AM
pulisher
12:28 PM

Insmed CEO William Lewis sells shares worth $2.71 million - MSN

12:28 PM
pulisher
Jan 20, 2025

Insmed Incorporated (NASDAQ:INSM) Short Interest Up 18.7% in December - MarketBeat

Jan 20, 2025
pulisher
Jan 20, 2025

Is Insmed (NASDAQ:INSM) Using Debt Sensibly? - Simply Wall St

Jan 20, 2025
pulisher
Jan 19, 2025

Insmed chief medical officer sells $95,108 in stock - MSN

Jan 19, 2025
pulisher
Jan 18, 2025

Is Insmed Incorporated (INSM) One of the Best Russell 2000 Stocks to Invest in According to Analysts? - Yahoo Finance

Jan 18, 2025
pulisher
Jan 18, 2025

Insmed (FRA:IM8N) Shares Outstanding (EOP) : 178.8 Mil (As of Sep. 2024) - GuruFocus.com

Jan 18, 2025
pulisher
Jan 18, 2025

Insmed's chief people strategy officer sells $59,923 in stock - MSN

Jan 18, 2025
pulisher
Jan 18, 2025

Goldman Sachs Sees High Merger Odds For This Large-Cap Biopharma In Trump 2.0 Era: Retail Has Been Alert - MSN

Jan 18, 2025
pulisher
Jan 17, 2025

Insmed Incorporated (NASDAQ:INSM) Insider Sells $95,108.48 in Stock - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Insmed Incorporated (NASDAQ:INSM) CEO William Lewis Sells 31,805 Shares of Stock - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Insmed COO Roger Adsett sells $100,125 in stock - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

Hennion & Walsh Asset Management Inc. Sells 43,522 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Insmed chief medical officer sells $95,108 in stock By Investing.com - Investing.com Australia

Jan 17, 2025
pulisher
Jan 17, 2025

Assenagon Asset Management S.A. Has $36.26 Million Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Jan 17, 2025
pulisher
Jan 16, 2025

Insider Sell: Roger Adsett Sells 1,457 Shares of Insmed Inc (INS - GuruFocus.com

Jan 16, 2025
pulisher
Jan 16, 2025

Insider Sell: Schaeffer Orlov S Nicole Sells Shares of Insmed In - GuruFocus.com

Jan 16, 2025
pulisher
Jan 16, 2025

Insmed's chief people strategy officer sells $59,923 in stock By Investing.com - Investing.com Australia

Jan 16, 2025
pulisher
Jan 16, 2025

Insmed COO Roger Adsett sells $100,125 in stock By Investing.com - Investing.com South Africa

Jan 16, 2025
pulisher
Jan 16, 2025

Insmed CEO William Lewis sells shares worth $2.71 million By Investing.com - Investing.com Canada

Jan 16, 2025
pulisher
Jan 15, 2025

Why INSM Stock Is Advancing Today - MSN

Jan 15, 2025
pulisher
Jan 15, 2025

Insmed’s gene therapy poised to challenge DMD landscape after IND clearance - Yahoo Finance

Jan 15, 2025
pulisher
Jan 14, 2025

Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.

Jan 14, 2025
pulisher
Jan 14, 2025

Capital CS Group LLC Buys New Stake in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Jan 14, 2025
pulisher
Jan 13, 2025

Insmed (NASDAQ:INSM) Stock Price Up 6%Should You Buy? - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

How Is The Market Feeling About Insmed? - Benzinga

Jan 13, 2025
pulisher
Jan 11, 2025

Insmed issues preliminary revenue results, guidance for Arikayce - MSN

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed COO Roger Adsett sells $368,472 in stock By Investing.com - Investing.com Nigeria

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed chief commercial officer sells shares worth $659,800 By Investing.com - Investing.com Australia

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed chief legal officer sells $242,815 in common stock By Investing.com - Investing.com Australia

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed’s chief medical officer sells $725,820 in stock By Investing.com - Investing.com Nigeria

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed's chief medical officer sells $725,820 in stock By Investing.com - Investing.com Australia

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed CFO Sara Bonstein sells $392,601 in stock By Investing.com - Investing.com Australia

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed Incorporated (NASDAQ:INSM) Stock Holdings Boosted by Harbor Capital Advisors Inc. - MarketBeat

Jan 11, 2025
pulisher
Jan 10, 2025

Insmed's chief medical officer sells $725,820 in stock - Investing.com India

Jan 10, 2025
pulisher
Jan 10, 2025

Insmed CFO Sara Bonstein sells $392,601 in stock - Investing.com India

Jan 10, 2025
pulisher
Jan 10, 2025

Insmed Incorporated (NASDAQ:INSM) CFO Sells $67,925.52 in Stock - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Insmed CEO William Lewis sells $995,012 in stock By Investing.com - Investing.com South Africa

Jan 10, 2025
pulisher
Jan 10, 2025

Insmed CEO William Lewis sells $995,012 in stock - Investing.com India

Jan 10, 2025
pulisher
Jan 10, 2025

Insmed chief people strategy officer sells shares worth $312,259 By Investing.com - Investing.com Canada

Jan 10, 2025

Insmed Inc (INSM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Insmed Inc (INSM) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Adsett Roger
Chief Operating Officer
Jan 14 '25
Sale
68.72
1,457
100,125
146,082
Schaeffer Orlov S Nicole
Chief People Strategy Officer
Jan 14 '25
Sale
68.72
872
59,924
97,083
Lewis William
Chair and CEO
Jan 15 '25
Option Exercise
22.76
18,750
426,750
411,339
Lewis William
Chair and CEO
Jan 15 '25
Option Exercise
10.85
6,830
74,106
240,754
Lewis William
Chair and CEO
Jan 15 '25
Sale
70.18
31,805
2,232,161
379,534
Lewis William
Chair and CEO
Jan 15 '25
Sale
70.17
6,830
479,295
233,924
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
大文字化:     |  ボリューム (24 時間):